WDNA vs. SCHG
Compare and contrast key facts about WisdomTree BioRevolution Fund (WDNA) and Schwab U.S. Large-Cap Growth ETF (SCHG).
WDNA and SCHG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Total Return Index. It was launched on Dec 11, 2009. Both WDNA and SCHG are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WDNA or SCHG.
Correlation
The correlation between WDNA and SCHG is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
WDNA vs. SCHG - Performance Comparison
Key characteristics
WDNA:
-0.48
SCHG:
2.22
WDNA:
-0.53
SCHG:
2.86
WDNA:
0.94
SCHG:
1.40
WDNA:
-0.22
SCHG:
3.13
WDNA:
-1.11
SCHG:
12.34
WDNA:
9.43%
SCHG:
3.14%
WDNA:
22.02%
SCHG:
17.45%
WDNA:
-51.90%
SCHG:
-34.59%
WDNA:
-47.12%
SCHG:
-2.75%
Returns By Period
In the year-to-date period, WDNA achieves a -13.52% return, which is significantly lower than SCHG's 37.04% return.
WDNA
-13.52%
-3.72%
-8.38%
-13.63%
N/A
N/A
SCHG
37.04%
3.40%
12.88%
37.14%
20.24%
16.77%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
WDNA vs. SCHG - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is higher than SCHG's 0.04% expense ratio.
Risk-Adjusted Performance
WDNA vs. SCHG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WDNA vs. SCHG - Dividend Comparison
WDNA has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.41%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 0.00% | 0.80% | 0.37% | 0.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHG Schwab U.S. Large-Cap Growth ETF | 0.41% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% | 1.09% | 1.07% |
Drawdowns
WDNA vs. SCHG - Drawdown Comparison
The maximum WDNA drawdown since its inception was -51.90%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for WDNA and SCHG. For additional features, visit the drawdowns tool.
Volatility
WDNA vs. SCHG - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.42% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 5.07%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.